Quick facts first cause this broke yesterday: Lilly filed six lawsuits against US retatrutide sellers - a med spa, a compounding pharmacy, and four RUO peptide shops (Astra, Legendary, Texas Peptides, Lone Star). But the suits are the loud part. The quiet part is Lilly formally asking payment processors, card networks, shipping companies and platforms to cut sellers off. thats the rails the whole market runs on.
And enforcement already moved before the lawsuits - customs seized almost 90,000 vials of illicit GLP-1s in july ALONE. more than double the pace of the entire previous year.
So here's our honest read on the next 6 months. numbered so you can hold us to it.
- Shops start vanishing overnight - and not the ones you'd expect. Processors and registrars don't wait for court rulings, they drop risk preemptively. Some perfectly functional shops will just be gone one morning. not cause they scammed anyone, cause Stripe or their registrar pulled the plug.
- Clone sites spike. every time a known shop vanishes and reappears under a new domain, impersonators exploit the confusion window. stolen COAs, copied branding, "we moved, new site here" scams. this is already the biggest fraud pattern we see and churn feeds it.
- "my package never came" becomes customs, not scams. seizures doubled in a month. a growing share of missing orders will be interceptions, not shops ripping people off. worth remembering before you one-star someone over a seized parcel.
- payment gets weirder. less cards, more crypto, more "email us for payment options." annoying, but on its own it stops being a scam signal - it becomes what compliant-processor-dropped shops do to survive.
- the word "retatrutide" starts disappearing from labels. this is the one that worries us. enforcement targets named product, so expect code names, blends, "GLP-3" nonsense, catalog numbers. which makes the only question that matters - whats actually in the vial - harder to even ask. verification gets more important precisely as it gets more awkward.
- prices go up. squeezed supply, seized shipments, fewer sellers. simple.
what we're NOT predicting: which specific shops survive, or that anyone named in the suits is guilty of anything - those are accusations, not verdicts.
the bigger arc, if you zoom out: montana built a legal lane, Lilly opened a narrow early-access gate, and now the gray lane gets squeezed. the direction is pretty clear even if the timeline isn't.
we'll grade all six of these in february, publicly, including the ones we got wrong.
what's your read - which of these is off? and if you've already seen a shop go dark or rebrand this week, say so below.